Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)
Clinical trial NCT01532648 · COMPLETED
Trial details
- NCT number
- NCT01532648
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-27
- Primary completion
- 2013-10-02
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.